Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 190

1.

Chlamydophila pneumoniae induces production of the defensin-like MIG/CXCL9, which has in vitro antichlamydial activity.

Balogh EP, Faludi I, Virók DP, Endrész V, Burián K.

Int J Med Microbiol. 2011 Mar;301(3):252-9. doi: 10.1016/j.ijmm.2010.08.020. Epub 2010 Nov 4.

PMID:
21056004
2.

Gene expression and production of the monokine induced by IFN-gamma (MIG), IFN-inducible T cell alpha chemoattractant (I-TAC), and IFN-gamma-inducible protein-10 (IP-10) chemokines by human neutrophils.

Gasperini S, Marchi M, Calzetti F, Laudanna C, Vicentini L, Olsen H, Murphy M, Liao F, Farber J, Cassatella MA.

J Immunol. 1999 Apr 15;162(8):4928-37.

3.

Chemokine monokine induced by IFN-gamma/CXC chemokine ligand 9 stimulates T lymphocyte proliferation and effector cytokine production.

Whiting D, Hsieh G, Yun JJ, Banerji A, Yao W, Fishbein MC, Belperio J, Strieter RM, Bonavida B, Ardehali A.

J Immunol. 2004 Jun 15;172(12):7417-24.

5.

Cutting edge: IFN-inducible ELR- CXC chemokines display defensin-like antimicrobial activity.

Cole AM, Ganz T, Liese AM, Burdick MD, Liu L, Strieter RM.

J Immunol. 2001 Jul 15;167(2):623-7.

6.

The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells.

Sauty A, Dziejman M, Taha RA, Iarossi AS, Neote K, Garcia-Zepeda EA, Hamid Q, Luster AD.

J Immunol. 1999 Mar 15;162(6):3549-58.

7.
8.

Human eosinophils produce the T cell-attracting chemokines MIG and IP-10 upon stimulation with IFN-gamma.

Dajotoy T, Andersson P, Bjartell A, Löfdahl CG, Tapper H, Egesten A.

J Leukoc Biol. 2004 Sep;76(3):685-91. Epub 2004 Jun 14.

PMID:
15197236
9.
10.

The CXC chemokine MIG/CXCL9 is important in innate immunity against Streptococcus pyogenes.

Egesten A, Eliasson M, Johansson HM, Olin AI, Morgelin M, Mueller A, Pease JE, Frick IM, Bjorck L.

J Infect Dis. 2007 Mar 1;195(5):684-93. Epub 2007 Jan 18.

PMID:
17262710
11.

Sulforaphane inhibits the interferon-γ-induced expression of MIG, IP-10 and I-TAC in INS‑1 pancreatic β-cells through the downregulation of IRF-1, STAT-1 and PKB.

Park YK, Ramalingam M, Kim S, Jang BC, Park JW.

Int J Mol Med. 2017 Sep;40(3):907-912. doi: 10.3892/ijmm.2017.3054. Epub 2017 Jul 3.

PMID:
28677733
12.

The T-lymphocyte chemoattractant Mig is highly expressed in vernal keratoconjunctivitis.

Abu El-Asrar AM, Struyf S, Al-Kharashi SA, Missotten L, Van Damme J, Geboes K.

Am J Ophthalmol. 2003 Nov;136(5):853-60.

PMID:
14597036
13.

Heparin displaces interferon-gamma-inducible chemokines (IP-10, I-TAC, and Mig) sequestered in the vasculature and inhibits the transendothelial migration and arterial recruitment of T cells.

Ranjbaran H, Wang Y, Manes TD, Yakimov AO, Akhtar S, Kluger MS, Pober JS, Tellides G.

Circulation. 2006 Sep 19;114(12):1293-300. Epub 2006 Aug 28.

PMID:
16940188
16.

The Toll-like receptor 5 stimulus bacterial flagellin induces maturation and chemokine production in human dendritic cells.

Means TK, Hayashi F, Smith KD, Aderem A, Luster AD.

J Immunol. 2003 May 15;170(10):5165-75.

17.

Regulated production of interferon-inducible T-cell chemoattractants by human intestinal epithelial cells.

Dwinell MB, Lügering N, Eckmann L, Kagnoff MF.

Gastroenterology. 2001 Jan;120(1):49-59.

PMID:
11208713
18.

Synthesis of alpha-chemokines IP-10, I-TAC, and MIG are differentially regulated in human corneal keratocytes.

McInnis KA, Britain A, Lausch RN, Oakes JE.

Invest Ophthalmol Vis Sci. 2005 May;46(5):1668-74.

PMID:
15851567
19.

Time course profile and cell-type-specific production of monokine induced by interferon-gamma in Concanavalin A-induced hepatic injury in mice: comparative study with interferon-inducible protein-10.

Itoh Y, Morita A, Nishioji K, Fujii H, Nakamura H, Kirishima T, Toyama T, Yamauchi N, Nagao Y, Narumi S, Okanoue T.

Scand J Gastroenterol. 2001 Dec;36(12):1344-51.

PMID:
11761028
20.

Monokine induced by IFN-gamma is a dominant factor directing T cells into murine cardiac allografts during acute rejection.

Miura M, Morita K, Kobayashi H, Hamilton TA, Burdick MD, Strieter RM, Fairchild RL.

J Immunol. 2001 Sep 15;167(6):3494-504.

Supplemental Content

Support Center